How to buy Madrigal Pharmaceuticals stock | $79.35

Madrigal Pharmaceuticals Inc is a biotechnology business based in the US. Madrigal Pharmaceuticals shares (MDGL) are listed on the NASDAQ and all prices are listed in US Dollars. Madrigal Pharmaceuticals employs 42 staff and has a market cap (total outstanding shares value) of 0.00.

Madrigal Pharmaceuticals stock price (NASDAQ: MDGL)

Use our graph to track the performance of MDGL stocks over time.

Madrigal Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-10-17.

Latest market close	$79.35
52-week range	$76.03 - $142.62
50-day moving average	$81.08
200-day moving average	$100.68
Wall St. target price	$170.08
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-14.61

Buy Madrigal Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Madrigal Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Madrigal Pharmaceuticals price performance over time

Historical closes compared with the close of $79.35 from 2021-10-20

1 week (2021-10-14)	-5.00%
1 month (2021-09-21)	1.16%
3 months (2021-07-21)	-15.23%
6 months (2021-04-21)	-38.19%

1 year (2020-10-21)	-37.56%
2 years (2019-10-21)	-9.71%
3 years (2018-10-19)	192.48
5 years (2016-10-21)	366.76%

Madrigal Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-40.67%
Return on equity TTM	-75.39%
Profit margin	0%
Book value	$16.31
Market capitalisation	$1.4 billion

TTM: trailing 12 months

Shorting Madrigal Pharmaceuticals shares

There are currently 1.4 million Madrigal Pharmaceuticals shares held short by investors – that's known as Madrigal Pharmaceuticals's "short interest". This figure is 0.2% down from 1.5 million last month.

There are a few different ways that this level of interest in shorting Madrigal Pharmaceuticals shares can be evaluated.

Madrigal Pharmaceuticals's "short interest ratio" (SIR)

Madrigal Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Madrigal Pharmaceuticals shares currently shorted divided by the average quantity of Madrigal Pharmaceuticals shares traded daily (recently around 108650.03750938). Madrigal Pharmaceuticals's SIR currently stands at 13.33. In other words for every 100,000 Madrigal Pharmaceuticals shares traded daily on the market, roughly 13330 shares are currently held short.

However Madrigal Pharmaceuticals's short interest can also be evaluated against the total number of Madrigal Pharmaceuticals shares, or, against the total number of tradable Madrigal Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Madrigal Pharmaceuticals's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Madrigal Pharmaceuticals shares in existence, roughly 90 shares are currently held short) or 0.173% of the tradable shares (for every 100,000 tradable Madrigal Pharmaceuticals shares, roughly 173 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Madrigal Pharmaceuticals.

Find out more about how you can short Madrigal Pharmaceuticals stock.

Madrigal Pharmaceuticals share dividends

We're not expecting Madrigal Pharmaceuticals to pay a dividend over the next 12 months.

Have Madrigal Pharmaceuticals's shares ever split?

Madrigal Pharmaceuticals's shares were split on a 1:35 basis on 24 July 2016. So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Madrigal Pharmaceuticals shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for Madrigal Pharmaceuticals shares which in turn could have impacted Madrigal Pharmaceuticals's share price.

Madrigal Pharmaceuticals share price volatility

Over the last 12 months, Madrigal Pharmaceuticals's shares have ranged in value from as little as $76.03 up to $142.62. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Madrigal Pharmaceuticals's is 1.1312. This would suggest that Madrigal Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Madrigal Pharmaceuticals overview

Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is MGL-3196, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania. .

Frequently asked questions

What percentage of Madrigal Pharmaceuticals is owned by insiders or institutions?
Currently 18.437% of Madrigal Pharmaceuticals shares are held by insiders and 85.599% by institutions. How many people work for Madrigal Pharmaceuticals?
Latest data suggests 42 work at Madrigal Pharmaceuticals. When does the fiscal year end for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals's fiscal year ends in December. Where is Madrigal Pharmaceuticals based?
Madrigal Pharmaceuticals's address is: Four Tower Bridge, West Conshohocken, PA, United States, 19428 What is Madrigal Pharmaceuticals's ISIN number?
Madrigal Pharmaceuticals's international securities identification number is: US5588681057 What is Madrigal Pharmaceuticals's CUSIP number?
Madrigal Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 558868105